Challenges in the rare diseases' space
Rare diseases are a large group of diseases that affect a very small percentage…
Can smart homes transform healthcare as we know it?
Smart home technology has already been transforming our everyday lives…
Gene therapy: invest or pass?
Big business for big pharma Gene therapy has the ability to dramatically…
The sleeping giant of nanomedicine
Nanomedicine applies the tools and knowledge of nanotechnology for the…
Medicines' pricing, what is fair and what is not?
‘Fair pricing’ of medicines – calls for transparency The rising cost of…
The rise of voice assistants in healthcare
The best option for managing your healthcare needs: Alexa, Google Assistant or…
Strengthening Pharma supply chains with technology
The past year showed us how quickly supply chains can be pushed to their limits…
Taking a view at the current multiple sclerosis landscape: hype, promises and successes...
The multiple sclerosis (MS) landscape includes several assets promising a…
Is the FDA ready for artificial intelligence and machine learning?
Software as a Medical Device (SaMD) - FDA’s AI/ML Plan The greatest advantage…
Resistance is futile...or maybe not?
Amid all the news on COVID-19, it is easy to forget about one of the greatest…
A lesser-known competitive strategy involving authorized generics
Authorized generics (AGs) is a less frequently heard terminology but an…
The next frontier: prescribing a breath of fresh air!
In this world of lockdowns and working from home it is important to dedicate…